257 related articles for article (PubMed ID: 24530641)
1. Gastrointestinal transition and anti-diabetic effect of Isabgol husk microparticles containing gliclazide.
Sharma VK; Mazumder B
Int J Biol Macromol; 2014 May; 66():15-25. PubMed ID: 24530641
[TBL] [Abstract][Full Text] [Related]
2. Controlling of systemic absorption of gliclazide through incorporation into alginate beads.
Al-Kassas RS; Al-Gohary OM; Al-Faadhel MM
Int J Pharm; 2007 Aug; 341(1-2):230-7. PubMed ID: 17507189
[TBL] [Abstract][Full Text] [Related]
3. Characterization of gliclazide release from Isabgol husk hydrogel beads by validated HPLC method.
Sharma VK; Mazumdar B
Acta Pol Pharm; 2014; 71(1):153-66. PubMed ID: 24779204
[TBL] [Abstract][Full Text] [Related]
4. Preparation and evaluation of mucinated sodium alginate microparticles for oral delivery of insulin.
Builders PF; Kunle OO; Okpaku LC; Builders MI; Attama AA; Adikwu MU
Eur J Pharm Biopharm; 2008 Nov; 70(3):777-83. PubMed ID: 18644444
[TBL] [Abstract][Full Text] [Related]
5. Preparation and evaluation of alginate-chitosan microspheres for oral delivery of insulin.
Zhang Y; Wei W; Lv P; Wang L; Ma G
Eur J Pharm Biopharm; 2011 Jan; 77(1):11-9. PubMed ID: 20933083
[TBL] [Abstract][Full Text] [Related]
6. Development, optimization, and anti-diabetic activity of gliclazide-loaded alginate-methyl cellulose mucoadhesive microcapsules.
Pal D; Nayak AK
AAPS PharmSciTech; 2011 Dec; 12(4):1431-41. PubMed ID: 22038475
[TBL] [Abstract][Full Text] [Related]
7. Design and development of gliclazide-loaded chitosan microparticles for oral sustained drug delivery: in-vitro/in-vivo evaluation.
Barakat NS; Almurshedi AS
J Pharm Pharmacol; 2011 Feb; 63(2):169-78. PubMed ID: 21235580
[TBL] [Abstract][Full Text] [Related]
8. Alginate microspheres of isoniazid for oral sustained drug delivery.
Rastogi R; Sultana Y; Aqil M; Ali A; Kumar S; Chuttani K; Mishra AK
Int J Pharm; 2007 Apr; 334(1-2):71-7. PubMed ID: 17113732
[TBL] [Abstract][Full Text] [Related]
9. Development of novel gastroretentive drug delivery system of gliclazide: hollow beads.
Awasthi R; Kulkarni GT
Drug Dev Ind Pharm; 2014 Mar; 40(3):398-408. PubMed ID: 23418961
[TBL] [Abstract][Full Text] [Related]
10. Formulation and optimization of alkaline extracted ispaghula husk microparticles of isoniazid - in vitro and in vivo assessment.
Maurya DP; Sultana Y; Aqil M; Kumar D; Chuttani K; Ali A; Mishra AK
J Microencapsul; 2011; 28(6):472-82. PubMed ID: 21561399
[TBL] [Abstract][Full Text] [Related]
11. A comprehensive study of novel microcapsules incorporating gliclazide and a permeation enhancing bile acid: hypoglycemic effect in an animal model of Type-1 diabetes.
Mathavan S; Chen-Tan N; Arfuso F; Al-Salami H
Drug Deliv; 2016 Oct; 23(8):2869-2880. PubMed ID: 26610261
[TBL] [Abstract][Full Text] [Related]
12. Chitosan oligosaccharide as prospective cross-linking agent for naproxen-loaded Ca-alginate microparticles with improved pH sensitivity.
Čalija B; Milić J; Cekić N; Krajišnik D; Daniels R; Savić S
Drug Dev Ind Pharm; 2013 Jan; 39(1):77-88. PubMed ID: 22339172
[TBL] [Abstract][Full Text] [Related]
13. Oral delivery of insulin from alginate/chitosan crosslinked by glutaraldehyde.
Tahtat D; Mahlous M; Benamer S; Khodja AN; Oussedik-Oumehdi H; Laraba-Djebari F
Int J Biol Macromol; 2013 Jul; 58():160-8. PubMed ID: 23567292
[TBL] [Abstract][Full Text] [Related]
14. Mucoadhesive microspheres of glutaraldehyde crosslinked mucilage of Isabgol husk for sustained release of gliclazide.
Sharma VK; Sharma PP; Mazumder B; Bhatnagar A; Subramaniyan V; Fuloria S; Fuloria NK
J Biomater Sci Polym Ed; 2021 Aug; 32(11):1420-1449. PubMed ID: 33941041
[TBL] [Abstract][Full Text] [Related]
15. Release and swelling studies of an innovative antidiabetic-bile acid microencapsulated formulation, as a novel targeted therapy for diabetes treatment.
Mooranian A; Negrulj R; Al-Sallami HS; Fang Z; Mikov M; Golocorbin-Kon S; Fakhoury M; Arfuso F; Al-Salami H
J Microencapsul; 2015; 32(2):151-6. PubMed ID: 25265061
[TBL] [Abstract][Full Text] [Related]
16. Development of novel gastroretentive floating particulate drug delivery system of gliclazide.
Awasthi R; Kulkarni GT
Curr Drug Deliv; 2012 Sep; 9(5):437-51. PubMed ID: 22920574
[TBL] [Abstract][Full Text] [Related]
17. Novel tamarind seed polysaccharide-alginate mucoadhesive microspheres for oral gliclazide delivery: in vitro-in vivo evaluation.
Pal D; Nayak AK
Drug Deliv; 2012 Apr; 19(3):123-31. PubMed ID: 22352984
[TBL] [Abstract][Full Text] [Related]
18. Design and development of gliclazide-loaded chitosan for oral sustained drug delivery: in vitro/in vivo evaluation.
Barakat NS; Almurshedi AS
J Microencapsul; 2011; 28(2):122-33. PubMed ID: 21110773
[TBL] [Abstract][Full Text] [Related]
19. The Influence of Chitosan Cross-linking on the Properties of Alginate Microparticles with Metformin Hydrochloride-In Vitro and In Vivo Evaluation.
Szekalska M; Sosnowska K; Zakrzeska A; Kasacka I; Lewandowska A; Winnicka K
Molecules; 2017 Jan; 22(1):. PubMed ID: 28117747
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of furosemide-loaded alginate microspheres prepared by ionotropic external gelation technique.
Das MK; Senapati PC
Acta Pol Pharm; 2007; 64(3):253-62. PubMed ID: 17695149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
